Vascular dementia
Cerebrovascular disease → stepwise cognitive decline
Overview
The second commonest dementia, from cerebrovascular disease. Classically a STEPWISE decline (each step after a vascular event) in a patient with vascular risk factors and focal neurological signs — distinct from the smooth decline of Alzheimer.
Recognise
- STEPWISE deterioration (plateaus then sudden drops), often after strokes/TIAs
- Vascular risk factors (hypertension, AF, diabetes, smoking); focal neurology, gait disturbance
- Patchy/"frontal" cognitive profile (slowed processing, executive/attention) rather than pure amnesia
Red flags
- Acute decline = new vascular event; manage stroke risk aggressively
Differentials & how to tell them apart
Investigations
Cognitive testing; MRI/CT (small-vessel disease, infarcts, white-matter change); vascular work-up (BP, glucose/HbA1c, lipids, ECG for AF); exclude reversible causes.
Management
Aggressive vascular secondary prevention; cholinesterase inhibitors only if coexisting Alzheimer
- 1Optimise vascular risk factors (BP, antiplatelet/anticoagulant, statin, diabetes, smoking) to slow progression; cognitive and functional support.Gate: Cholinesterase inhibitors are NOT routinely used for pure vascular dementia — reserve them for mixed/coexisting Alzheimer disease
- 2Treat the underlying cerebrovascular disease; manage mood and behaviour; carer support.
Key points
Stepwise decline + vascular risk + focal signs = vascular dementia; smooth amnestic decline = Alzheimer. Many have BOTH (mixed) — see the Mixed dementia card.
Monitor & prognosis
Vascular risk control, cognition, function, new events.
Stepwise progression; slowed by vascular risk-factor control.
Source: NICE NG97 (dementia)